This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/5/2026
JL
Conference Operator
Good morning and welcome to the United Therapeutics Corporation second quarter 2026 corporate update. My name is JL and I'll be a conference operator today. All participants on the call portion of this webcast will be in a listen-only mode until the question and answer portion of the earnings call. If you'd like to ask a question during this time, simply press star then the number one on your telephone keypad. If you'd like to withdraw your question, simply press star one again.
Harry Silvers
Investor Relations, United Therapeutics Corporation
Please note that this call is being recorded.
JL
Conference Operator
I'll now turn the webcast over to Harry Silvers, Investor Relations at United Therapeutics.
You're reading a preview of the UTHR Q2 2026 earnings call.
Free account.
Disclaimer